Suppression of inflammation by a synthetic histone mimic

Edwige Nicodème, Kate L. Jeffrey(Rockefeller University), Uwe Schaefer(Rockefeller University), Sören Beinke(GlaxoSmithKline (United Kingdom)), Scott Dewell(Rockefeller University), Chun‐wa Chung(GlaxoSmithKline (United Kingdom)), Rohit Chandwani(Rockefeller University), Ivan Marazzi(Rockefeller University), Paul A. Wilson(GlaxoSmithKline (United Kingdom)), Hervé Coste(GlaxoSmithKline (France)), Julia H. White(GlaxoSmithKline (United Kingdom)), Jorge Kirilovsky(GlaxoSmithKline (France)), Charles M. Rice(Rockefeller University), José M. Lora(GlaxoSmithKline (United Kingdom)), Rab K. Prinjha(GlaxoSmithKline (United Kingdom)), Kevin Lee(GlaxoSmithKline (United Kingdom)), Alexander Tarakhovsky(Rockefeller University)
Nature
November 10, 2010
10.1038/nature09589
Cited by 1,567Open Access
Full Text

Abstract

Related Papers

Immunodesign of experimental sepsis by cecal ligation and puncture
Daniel Rittirsch, Markus Huber‐Lang, Michael A. Flierl et al.|Nature Protocols|2008|2.2k
How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers
Sean D. Taverna, Haitao Li, Alexander J. Ruthenburg et al.|Nature Structural & Molecular Biology|2007|1.4k
The Bromodomain Protein Brd4 Is a Positive Regulatory Component of P-TEFb and Stimulates RNA Polymerase II-Dependent Transcription
Moon Kyoo Jang, Kazuki Mochizuki, Meisheng Zhou et al.|Molecular Cell|2005|1.3k
Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions
Aaron D. Goldberg, Laura A. Banaszynski, Kyung‐Min Noh et al.|Cell|2010|1.3k
An extensive network of coupling among gene expression machines
Tom Maniatis, Robin Reed|Nature|2002|1.1k